West Oak Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-150
Closed -$3K 321
2023
Q3
$3K Hold
150
﹤0.01% 280
2023
Q2
$3.8K Hold
150
﹤0.01% 283
2023
Q1
$3.88K Buy
150
+60
+67% +$1.61K ﹤0.01% 282
2022
Q4
$2K Sell
90
-60
-40% -$1.62K ﹤0.01% 264
2022
Q3
$4K Hold
150
﹤0.01% 290
2022
Q2
$5K Hold
150
﹤0.01% 276
2022
Q1
$11K Hold
150
0.01% 259
2021
Q4
$14K Sell
150
-90
-38% -$10.8K 0.01% 251
2021
Q3
$30K Buy
240
+38
+19% +$5.53K 0.01% 217
2021
Q2
$34K Hold
202
0.01% 208
2021
Q1
$37K Hold
202
0.02% 198
2020
Q4
$40K Buy
+202
New +$41.1K 0.02% 188

Other funds holding TDOC

West Oak Capital's TDOC Position: Q4 2023 in Review

West Oak Capital sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 150 shares — an estimated $3K sold.

West Oak Capital first reported a position in TDOC in Q4 2020 and held it in 12 quarters. The position peaked at $40K in Q4 2020. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • West Oak Capital reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • West Oak Capital sold 150 Teladoc Health shares in Q4 2023, an estimated $3K.
  • West Oak Capital first reported a position in Teladoc Health in Q4 2020 and held it in 12 quarters.
  • West Oak Capital's Teladoc Health position peaked at $40K in Q4 2020.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on West Oak Capital's 13F filing for Q4 2023, filed 18 Jan 2024.